Symbols

SCL

Stepan·NYSE

--(--)

SCL fundamentals

SCL Q4 2025 Earnings

Stepan (SCL) released its earnings on Feb 23, 2026: revenue was 553.89M (YoY +5.38%), missed estimates; EPS was -0.02 (YoY -116.67%), missed estimates.

Revenue / YoY

553.89M

+5.38%

EPS / YoY

-0.02

-116.67%

Report date

Feb 23, 2026

SCL Earnings Call Summary for Q4,2025

2025 Performance: Adjusted EBITDA up 6% to $199 million; free cash flow positive at $25.4 million; dividend increased 2.6%.
Project Catalyst: $100M savings over two years ($60M in 2026), targeting cost efficiency and growth flexibility.
Q1 2026 Challenges: $6M EBITDA impact from winter weather, with recovery potential in later quarters.
Growth Drivers: Tier 2/Tier 3 segment expansion and sulfate-free personal care solutions.

Earnings

EPS

Revenue

Revenue & Expenses

SCL has released its 2025 Q4 earnings report, with revenue of 553.89M, reflecting a YoY change of 5.38%, and net profit of 5.00M, showing a YoY change of 49.37%. The Sankey diagram below clearly presents SCL's revenue sources and cost distribution.

Key Indicators

Stepan (SCL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Stepan (SCL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Stepan (SCL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Stepan (SCL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown